Herbas VPB

Print
EN | LT
LT - Antikūno molekulės TIM-3-čiam ir jų panaudojimas
EN - ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
A61K 45/06 (2006.01)
G01N 33/68 (2006.01)
European patent
(11) Number of the document 3099717
(13) Kind of document T
(96) European patent application number 15705163.2
Date of filing the European patent application 2015-01-30
(97) Date of publication of the European application 2016-12-07
(45) Date of publication and mention of the grant of the patent 2019-03-27
(46) Date of publication of the claims translation 2019-09-10
PCT application
(86) Number PCT/US2015/013913
Date 2015-01-30
PCT application publication
(87) Number WO 2015/117002
Date 2015-08-06
Priority applications
(30) Number Date Country code
201461934469 P 2014-01-31 US
201462094912 P 2014-12-19 US
Inventors
(72)
SABATOS-PEYTON, Catherine, Anne, US
BRANNETTI, Barbara, CH
HARRIS, Alan, S., US
HUBER, Thomas, CH
PIETZONKA, Thomas, CH
MATARAZA, Jennifer, Marie, US
BLATTLER, Walter, A., US
HICKLIN, Daniel, J., US
VASQUEZ, Maximiliano, US
DEKRUYFF, Rosemarie, H., US
UMETSU, Dale, T., US
FREEMAN, Gordon, James, US
HU, Tiancen, US
TARASZKA, John, A., US
XU, Fangmin, US
Grantee
(73) Novartis AG, Lichtstrasse 35, 4056 Basel, CH
Children`s Medical Center Corporation, 55 Shattuck Street, Boston, MA 02115, US
Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, Boston, MA 02215-5450, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Antikūno molekulės TIM-3-čiam ir jų panaudojimas
  ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
Last renewal fee
Payment date Validity (years) Amount
2023-12-22 10 231.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2025-01-30